Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Short-Term Debt issuances (2023 - 2025)

Cannabis Bioscience International Holdings filings provide 3 years of Short-Term Debt issuances readings, the most recent being -$24612.0 for Q2 2025.

  • On a quarterly basis, Short-Term Debt issuances fell 2461300.0% to -$24612.0 in Q2 2025 year-over-year; TTM through May 2025 was -$24472.0, a 181.96% decrease, with the full-year FY2025 number at -$24472.0, down 181.96% from a year prior.
  • Short-Term Debt issuances reached -$24612.0 in Q2 2025 per CBIH's latest filing, up from -$77297.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $116075.0 in Q4 2024, with the low at -$77297.0 in Q1 2025.
  • A 3-year average of $1489.1 and a median of $2306.5 in 2023 define the central range for Short-Term Debt issuances.
  • Year-over-year, Short-Term Debt issuances skyrocketed 510.49% in 2024 and then crashed 2461300.0% in 2025.
  • Year by year, Short-Term Debt issuances stood at -$33481.0 in 2023, then surged by 446.69% to $116075.0 in 2024, then plummeted by 121.2% to -$24612.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Short-Term Debt issuances are -$24612.0 (Q2 2025), -$77297.0 (Q1 2025), and $116075.0 (Q4 2024).